Skip to main content
KYNB $5.24 -0.76%
KYNB logo
KYNB · Kyntra Bio, Inc.
Track KYNB — free
$5.24 -0.04 (-0.76%)
Market Cap
$21.38M
Shares
4.05M
Volume · Oct 21 7418 Avg daily vol (3M) 19.56K
All webcasts

Earnings call · FY2022 Q1

Kyntra Bio, Inc. (KYNB) Q1 2022 Earnings Call

Concluded May 9, 2022
May 9, 2022 0 turns
Period
FY2022 Q1
Runtime
—
Sources
2 artifacts
Revenue $60.83M +58.3% YoY
Diluted EPS -$17.00
Net income -$63.20M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Forward guidance

1 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed May 9, 2022.

Metric Guided
2022 ending cash balance
2022
$310M – $340M

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

License$22.59M
Product$18.88M +22.9% YoY
Development and Other Revenue$11.76M -19.4% YoY
Drug Product Revenue$7.59M -10.4% YoY
Full-screen source Call document